AI and app team up to track MS in new digital health study

NCT ID NCT05949580

Recruiting now Knowledge-focused Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new digital platform helps doctors monitor people with multiple sclerosis (MS) more effectively. The platform includes an AI tool that analyzes brain scans and a patient app for tracking symptoms and medications. Researchers will enroll 500 people with relapsing-remitting MS to see if this digital approach improves care over two years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING REMITTING MULTIPLE SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hackensack University Medical Center
RECRUITING

Hackensack, New Jersey, 07601, United States
Jersey Shore University Medical Centre
RECRUITING

Neptune City, New Jersey, 07753, United States
Minneapolis Clinic of Neurology
RECRUITING

Golden Valley, Minnesota, 55422, United States
Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim
RECRUITING

Sinsheim, 74889, Germany
Universitaetsklinikum Carl Gustav Carus an der TU Dresden
RECRUITING

Dresden, 01307, Germany

Conditions

Explore the condition pages connected to this study.

RELAPSING REMITTING MULTIPLE SCLEROSIS